Press Releases

Other News

Aug 18 2023
Redeye interviewed Øystein Rekdal about Lytix and his role as CEO
Aug 14 2023
The positive interim Phase II data with LTX-315 from Verrica Pharmaceuticals Inc. (Lytix Biopharma’s licensing partner) stirs attention
Aug 10 2023
Redeye initiates coverage of Lytix Biopharma
May 30 2023
Lytix Biopharma’s innovative and unique solution emphasized in national clinical research report
May 12 2023
Hear our CEO, Øystein Rekdal, explaining how our technology has the potential to solve the major challenge in current cancer therapy